Clinical trial
Symptom Adapted Therapy in GERD Patients
NCT00343161 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00343161 |
|---|---|
| Title | Symptom Adapted Therapy in GERD Patients |
| Official title | A Randomized, Open, Parallel-group, Multi-national, Multi-centre, Phase IV Study to Evaluate the Efficacy of Three Different Patient Management Strategies With and Without Esomeprazole 20 mg During a 3 Months Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With… |
| Acronym | SYMPATHY |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | esomeprazole, Gelusil-Lac (Aluminum hydroxide gel, magnesium trisilicate) |
| Enrollment | 441 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 22, 2006 |
| Last update posted | Jan 24, 2011 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: